Weight Loss Injections and Lipoedema

Join us to learn about City St George’s, University of London latest research project.

The project explores the experiences of people with lipoedema who have used GLP-1/GIP weight loss medications such as Ozempic, Wegovy, Mounjaro and Saxenda.

The survey is being organised by UK doctor Nicole Lim-Wann-Jie as part of the research team at City St George’s, University of London.

Although these medications are not currently licensed or approved for the treatment of lipoedema, increasing numbers of people with lipoedema are trying them. At present, there is very limited research into whether these medications have any impact on lipoedema symptoms, experiences, or quality of life.

During this webinar, Nicole will:

• Share an update on the research project at City St George’s, University of London
• Explain her role in the study and why she is interested in researching lipoedema
• Discuss what the team hopes to learn
• Explain how people can take part in the study
• Explore why gathering real-world data from the lipoedema community is so important

This research aims to better understand the experiences of people with lipoedema who have used GLP-1/GIP medications, helping to inform future research and clinical understanding.

About the Survey

The study involves an anonymous online survey designed to gather experiences from people with lipoedema who have used weight loss injections.

What the survey involves

• Approximately 10–15 minutes to complete
• Approximately 40 questions
• Anonymous participation
• An opportunity to share your personal experience
• Contributing to research that may help inform future approaches to lipoedema care and support

You may be eligible if you:

• Are aged 18 or over
• Have lipoedema (clinician-diagnosed or self-diagnosed)
• Are currently using, or have previously used, any GLP-1/GIP weight loss injection for 3 months or longer
• Have taken your last dose within the past 12 months
• Are able to complete an online survey in English, independently or with assistance
• Live anywhere in the world

Please note: these medications are not currently licensed or approved for the treatment of lipoedema. This study explores participants’ experiences of this off-label use.

Take Part in the Survey

Click here to complete the survey!